These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2290976)

  • 41. Parkinson disease. Stem cell transplantation.
    Lindvall O
    Lancet; 2001 Dec; 358 Suppl():S48. PubMed ID: 11784596
    [No Abstract]   [Full Text] [Related]  

  • 42. Neuroscience. Fetal cells again?
    Holden C
    Science; 2009 Oct; 326(5951):358-9. PubMed ID: 19833936
    [No Abstract]   [Full Text] [Related]  

  • 43. Cell therapy for Parkinson's disease.
    Fischbach GD; McKhann GM
    N Engl J Med; 2001 Mar; 344(10):763-5. PubMed ID: 11236783
    [No Abstract]   [Full Text] [Related]  

  • 44. Development of fetal neural transplantation as a treatment for Parkinson's disease.
    Clarkson ED; Freed CR
    Life Sci; 1999 Oct; 65(23):2427-37. PubMed ID: 10622227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants.
    Lindvall O; Widner H; Rehncrona S; Brundin P; Odin P; Gustavii B; Frackowiak R; Leenders KL; Sawle G; Rothwell JC
    Ann Neurol; 1992 Feb; 31(2):155-65. PubMed ID: 1575454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychiatric status after human fetal mesencephalic tissue transplantation in Parkinson's disease.
    Price LH; Spencer DD; Marek KL; Robbins RJ; Leranth C; Farhi A; Naftolin F; Roth RH; Bunney BS; Hoffer PB
    Biol Psychiatry; 1995 Oct; 38(8):498-505. PubMed ID: 8562661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neural transplantation.
    Ulrisch R; Jacques S; Kopyov O
    J Neurosurg; 2000 Jul; 93(1):163-4. PubMed ID: 10883934
    [No Abstract]   [Full Text] [Related]  

  • 48. Cerebral implantation in movement disorders: state of the art.
    Lindvall O
    Mov Disord; 1999 Mar; 14(2):201-5. PubMed ID: 10091610
    [No Abstract]   [Full Text] [Related]  

  • 49. Embryos and Parkinson's disease.
    Hitchcock ER; Clough C; Hughes R; Kenny B
    Lancet; 1988 Jun; 1(8597):1274. PubMed ID: 2897530
    [No Abstract]   [Full Text] [Related]  

  • 50. Regression of parkinsonian fetal ventral mesencephalon grafts upon withdrawal of cyclosporine A immunosuppression. The CPH Neural Transplantation Group.
    Lopez-Lozano JJ; Bravo G; Brera B; Dargallo J; Salmean J; Uria J; Insausti J; Martinez R; Sanchez P; de la Torre C; Moreno R
    Transplant Proc; 1997; 29(1-2):977-80. PubMed ID: 9123614
    [No Abstract]   [Full Text] [Related]  

  • 51. Cryopreservation of porcine fetal ventral mesencephalic tissue for intrastriatal transplantation in Parkinson's disease.
    Koopmans J; HogenEsch I; Copray S; Middel B; van Dijk H; Go KG; Staal M
    Cell Transplant; 2001; 10(7):573-81. PubMed ID: 11714191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of foetal human brain tissue as brain implants: phenotype manipulation by genetic manipulation and biochemical induction.
    Bradford HF
    Keio J Med; 2002 Sep; 51(3):148-53. PubMed ID: 12371646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve terminals.
    Freed CR; Breeze RE; Rosenberg NL; Schneck SA
    Adv Neurol; 1993; 60():721-8. PubMed ID: 8420217
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of Parkinson's disease by cell transplantation.
    Cesaro P; Peschanski M; N'Guyen JP
    Funct Neurol; 2001; 16(1):21-7. PubMed ID: 11396267
    [No Abstract]   [Full Text] [Related]  

  • 55. Role of cell therapy in Parkinson disease.
    Lindvall O; Hagell P
    Neurosurg Focus; 2002 Nov; 13(5):e2. PubMed ID: 15769071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
    Kirik D; Björklund A
    Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
    [No Abstract]   [Full Text] [Related]  

  • 57. Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites.
    Bankiewicz KS; Plunkett RJ; Mefford I; Kopin IJ; Oldfield EH
    Prog Brain Res; 1990; 82():561-71. PubMed ID: 1705356
    [No Abstract]   [Full Text] [Related]  

  • 58. Improved surgical cell therapy in Parkinson's disease. Physiological basis and new transplantation methodology.
    Isacson O; van Horne C; Schumacher JM; Brownell AL
    Adv Neurol; 2001; 86():447-54. PubMed ID: 11554007
    [No Abstract]   [Full Text] [Related]  

  • 59. Stereotaxic implantation of autologous adrenal medulla into caudate nucleus in four patients with parkinsonism. One-year follow-up.
    Fazzini E; Dwork AJ; Blum C; Burke R; Cote L; Goodman RR; Jacobs TP; Naini AB; Pezzoli G; Pullman S
    Arch Neurol; 1991 Aug; 48(8):813-20. PubMed ID: 1845109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of L-dopa and carbidopa on behavioural recovery produced by ventral mesencephalic grafts in rats.
    Blunt SB; Jenner P; Marsden CD
    Prog Brain Res; 1990; 82():493-8. PubMed ID: 2127116
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.